Compare FTRE & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTRE | WEN |
|---|---|---|
| Founded | 1996 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2023 | 1999 |
| Metric | FTRE | WEN |
|---|---|---|
| Price | $10.63 | $7.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 22 |
| Target Price | ★ $15.39 | $8.88 |
| AVG Volume (30 Days) | 2.0M | ★ 10.6M |
| Earning Date | 05-25-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 7.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.85 |
| Revenue | ★ $2,723,400,000.00 | $2,176,891,000.00 |
| Revenue This Year | $2.45 | $2.76 |
| Revenue Next Year | $3.08 | $1.07 |
| P/E Ratio | ★ N/A | $8.98 |
| Revenue Growth | ★ 1.00 | N/A |
| 52 Week Low | $3.97 | $6.73 |
| 52 Week High | $18.67 | $15.79 |
| Indicator | FTRE | WEN |
|---|---|---|
| Relative Strength Index (RSI) | 34.30 | 42.41 |
| Support Level | $9.35 | $6.73 |
| Resistance Level | $11.46 | $8.56 |
| Average True Range (ATR) | 1.16 | 0.46 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 26.76 | 41.05 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.